CGS 20625, a novel pyrazolopyridine with selective anxiolytic activity.
Jarvis
M F
MF
Research Department, CIBA-GEIGY Corp. Summit, NJ 07901.
Bennett
D A
DA
Loo
P A
PA
Braunwalder
A F
AF
Thompson
T N
TN
Schmutz
M
M
Yokoyoma
N
N
Wasley
J W
JW
Williams
M
M
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000493:pharmacokinetics / Q000494:pharmacology*; D001682:Biological Availability; D003975:Diazepam / Q000494:pharmacology; D005445:Flunitrazepam / Q000378:metabolism; D007858:Learning / Q000187:drug effects; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D011720:Pyrazoles / Q000493:pharmacokinetics / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D017981:Receptors, Neurotransmitter / Q000378:metabolism
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D011720:Pyrazoles; D017981:Receptors, Neurotransmitter; C054732:CGS 20625; D005445:Flunitrazepam; D003975:Diazepam